Clinically Supported Weight Loss Treatment with Tirzepatide Injections

Real Results from Clinical Trials

Clinical studies show that Mounjaro promotes fat loss while maintaining lean muscle mass, leading to healthier, more sustainable weight loss. Adults lost between 12 lbs (5 mg dose) and 25 lbs (15 mg dose) with Mounjaro, whether used alone or with other diabetes medications.

The SURMOUNT-3 trial also evaluated Mounjaro in adults with obesity or overweight and weight-related conditions. After 12 weeks of lifestyle intervention, participants lost 6.9% (~16.8 lbs) of body weight. Those who continued Mounjaro for an additional 72 weeks lost another 21.1%, bringing total weight loss to 26.6% (~64.4 lbs) over 84 weeks.

The placebo group lost only 3.8% (~9 lbs). 94.4% of Mounjaro users lost at least 5% of their body weight (vs. 10.7% on placebo), and 54.9% lost 20% or more (vs. 1% on placebo). The most common side effects were mild to moderate nausea, diarrhea, and constipation.

These studies have also shown that individuals who stopped using Mounjaro experienced a weight gain of 14% one year after they stopped using the drug. However, their weight did not return to baseline levels, which shows that some of the weight loss was sustained over time.

Mounjaro Injections for Weight Loss

Mounjaro is an injectable medication that is prescribed off-label for weight loss. Similar to Wegovy, it is self-administered and taken once a week. The injections come in a user-friendly pen and can be administered in the thigh, abdomen, or upper arm. It is recommended to use the injections once a week, rotating the injection site each week to avoid irritation.

During the first month, weight loss may not be very noticeable, but you may begin to experience changes in your appetite, such as feeling less hungry and having fewer cravings. This is an ideal time to incorporate healthy lifestyle changes, including regular exercise and a balanced diet to get better and lasting weight loss results.

By the second month, the dosage is typically increased to 5 mg, and many patients begin to notice a more significant difference in their weight, appetite, and cravings. On average, patients may experience around a 6% weight loss by the end of the second month. From months 3 to 6, the dosage is gradually increased to 7.5 to 15mg, depending on individual tolerance and response. With consistent use over 18 months, patients can expect to lose approximately 21% of their starting body weight.